Pulmatrix (PULM) Other financing activities (2013 - 2021)
Pulmatrix (PULM) posted Other financing activities of $204000.0 for Q1 2021, down 98.5% sequentially from $13.6 million in Q4 2020, and down 14.64% YoY from $239000.0 in Q1 2020.
Pulmatrix (PULM) Other financing activities (2013 - 2021) Analysis & Trends
Pulmatrix has reported Other financing activities for 6 years, with the latest figure at $204000.0 in Q1 2021.
- Quarterly Other financing activities fell 14.64% year-over-year to $204000.0 in Q1 2021, while the trailing twelve-month figure through Dec 2021 was $204000.0 (down 98.74% YoY) and the FY2021 annual result came in at $204000.0, down 98.5% from the prior year.
- Other financing activities declined to $204000.0 in Q1 2021 per PULM's latest filing, from $13.6 million in the prior quarter.
- Over five years, Other financing activities peaked at $13.6 million in Q4 2020 and troughed at $3000.0 in Q4 2019.
- A 4-year average of $1.5 million and a median of $83000.0 in 2019 frame the typical range for Other financing activities.
- The widest YoY moves for Other financing activities: up 453866.67% in 2020, down 96.39% in 2020.
- Over 4 years, Other financing activities stood at $4000.0 in 2017, then retreated by 25.0% to $3000.0 in 2019, then jumped by 453866.67% to $13.6 million in 2020, then slumped by 98.5% to $204000.0 in 2021.
- According to Business Quant data, Other financing activities over the past three periods registered $204000.0, $13.6 million, and $2.3 million for Q1 2021, Q4 2020, and Q3 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Pulmatrix | 5.46 Mn | 5.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 204,000.00 |
| Mar 31, 2021 | 204,000.00 |
| Dec 31, 2020 | 13.62 Mn |
| Dec 31, 2020 | 13.62 Mn |
| Sep 30, 2020 | 2.29 Mn |
| Sep 30, 2020 | 2.29 Mn |
| Jun 30, 2020 | 3,000.00 |
| Jun 30, 2020 | 3,000.00 |
| Mar 31, 2020 | 239,000.00 |
| Mar 31, 2020 | 239,000.00 |
| Dec 31, 2019 | 3,000.00 |
| Dec 31, 2019 | 3,000.00 |
| Sep 30, 2019 | 4,000.00 |
| Sep 30, 2019 | 4,000.00 |
| Jun 30, 2019 | 83,000.00 |
| Jun 30, 2019 | 83,000.00 |
| Mar 31, 2019 | 70,000.00 |
| Mar 31, 2019 | 70,000.00 |
| Jun 30, 2017 | 4,000.00 |
| Jun 30, 2017 | 4,000.00 |